A detailed history of Voya Investment Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Voya Investment Management LLC holds 8,660 shares of CRSP stock, worth $414,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,660
Previous 16,455 47.37%
Holding current value
$414,640
Previous $888,000 54.28%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$44.62 - $62.75 $347,812 - $489,136
-7,795 Reduced 47.37%
8,660 $406,000
Q2 2024

Aug 14, 2024

SELL
$51.17 - $68.18 $506,122 - $674,368
-9,891 Reduced 37.54%
16,455 $888,000
Q4 2023

Feb 14, 2024

BUY
$38.62 - $72.18 $237,551 - $443,979
6,151 Added 30.46%
26,346 $1.65 Million
Q3 2023

Nov 14, 2023

BUY
$45.39 - $59.0 $360,215 - $468,224
7,936 Added 64.74%
20,195 $916,000
Q2 2023

Aug 14, 2023

SELL
$43.47 - $67.77 $9,780 - $15,248
-225 Reduced 1.8%
12,259 $688,000
Q1 2023

May 15, 2023

SELL
$41.0 - $56.12 $395,445 - $541,277
-9,645 Reduced 43.59%
12,484 $564,000
Q4 2022

Feb 14, 2023

BUY
$39.19 - $65.67 $10,542 - $17,665
269 Added 1.23%
22,129 $899,000
Q3 2022

Mar 03, 2023

SELL
$61.1 - $83.78 $16,435 - $22,536
-269 Reduced 1.22%
21,860 $1.43 Million
Q3 2022

Nov 14, 2022

BUY
$61.1 - $83.78 $1.34 Million - $1.83 Million
21,860 New
21,860 $1.43 Million
Q1 2020

May 15, 2020

SELL
$33.68 - $62.53 $127,748 - $237,176
-3,793 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.68 - $73.13 $139,127 - $277,382
3,793 New
3,793 $231,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.